The GLP is committed to full transparency. Download and review our 2019 Annual Report

Peanut allergy treatments change DNA of the immune cells

| | February 3, 2014
This article or excerpt is included in the GLP’s daily curated selection of ideologically diverse news, opinion and analysis of biotechnology innovation.

Scientists with Stanford University are finding that healing a peanut allergy with oral immunotherapy alters the DNA of the patient’s immune cells. The finding could serve as the basis for a simple blood test to monitor the long-term effectiveness of the allergy therapy.

Allergy scientists are performing clinical trials of doctor-supervised immunotherapy involving peanut-allergy sufferers taking escalating amounts of peanut powder in an attempt to desensitize them to the nuts. At the conclusion of the trial, patients are usually expected to eat some peanuts every day throughout their lives.

Read the full, original story: DNA Verification Of Peanut Allergy Treatments

Share via
News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.
Send this to a friend